Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF-κB signaling pathway

Cryptotanshinone (CRY) has been demonstrated to reverse reproductive disorders. However, whether CRY is effective in the treatment of polycystic ovary syndrome (PCOS) remains unknown. The aim of the present study was to evaluate the therapeutic potential of CRY in PCOS. A rat model of PCOS was estab...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yijiao, Yang, Ling, Qi, Cao, Hu, Guohua, Wang, Longhui, Sun, Zhuojun, Ni, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533513/
https://www.ncbi.nlm.nih.gov/pubmed/32901834
http://dx.doi.org/10.3892/mmr.2020.11469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533513/
https://www.ncbi.nlm.nih.gov/pubmed/32901834
http://dx.doi.org/10.3892/mmr.2020.11469

Ejemplares similares